Literature DB >> 10684590

What transgenic mice tell us about neurodegenerative disease.

M E Gurney1.   

Abstract

The recent broad advance in our understanding of human neurodegenerative diseases is based on the application of a new molecular approach. Through linkage analysis, the genes responsible for Huntington's disease, the spinocerebellar ataxias, and familial forms of Alzheimer's disease and amyotrophic lateral sclerosis (ALS) have been identified and cloned. The characterization of pathogenic mutations in such genes allows the creation of informative transgenic mouse models as, without exception, the genetic forms of adult neurodegenerative disease are due to toxicity of the mutant protein. Transgenic models provide insight into the oxidative mechanisms in ALS pathogenesis, the pathogenicity of expanded polyglutamine tracts in CAG triplet repeat disorders, and amyloidogenesis in Alzheimer's disease. Although such models have their limitations, they currently provide the best entry point for the study of human neurodegenerative diseases. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10684590     DOI: 10.1002/(SICI)1521-1878(200003)22:3<297::AID-BIES12>3.0.CO;2-I

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  11 in total

Review 1.  Vaccines for Alzheimer's disease: how close are we?

Authors:  Christopher Janus
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G⁹³A transgenic ALS mice.

Authors:  P Hande Ozdinler; Susanna Benn; Ted H Yamamoto; Mine Güzel; Robert H Brown; Jeffrey D Macklis
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

3.  Noninvasive detection of brainstem and spinal cord axonal degeneration in an amyotrophic lateral sclerosis mouse model.

Authors:  Joong Hee Kim; Tzy-Haw Wu; Matthew D Budde; Jin-Moo Lee; Sheng-Kwei Song
Journal:  NMR Biomed       Date:  2010-12-08       Impact factor: 4.044

Review 4.  Mechanisms of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  S Cluskey; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

Review 5.  Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2014-02       Impact factor: 5.243

6.  Liver X receptor beta (LXRbeta): a link between beta-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementia.

Authors:  Hyun-Jin Kim; Xiaotang Fan; Chiara Gabbi; Konstantin Yakimchuk; Paolo Parini; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-31       Impact factor: 11.205

7.  The role of dietary antioxidant insufficiency on the permeability of the blood-brain barrier.

Authors:  Hussni O Mohammed; Simon R Starkey; Korona Stipetic; Thomas J Divers; Brian A Summers; Alexander de Lahunta
Journal:  J Neuropathol Exp Neurol       Date:  2008-12       Impact factor: 3.685

Review 8.  Misfolded CuZnSOD and amyotrophic lateral sclerosis.

Authors:  Joan Selverstone Valentine; P John Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

9.  Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Luis B Tovar-Y-Romo; Luz Diana Santa-Cruz; Ricardo Tapia
Journal:  Mol Neurodegener       Date:  2009-07-20       Impact factor: 14.195

10.  An in vitro model for Lewy body-like hyaline inclusion/astrocytic hyaline inclusion: induction by ER stress with an ALS-linked SOD1 mutation.

Authors:  Satoru Yamagishi; Yoshihisa Koyama; Taiichi Katayama; Manabu Taniguchi; Junichi Hitomi; Masaaki Kato; Masashi Aoki; Yasuto Itoyama; Shinsuke Kato; Masaya Tohyama
Journal:  PLoS One       Date:  2007-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.